Abstract
Sickle cell hemoglobin (HbS) is a variant of adult hemoglobin due to mutation of beta chain of globin, which leads to substitution of valine amino acid for glutamic acid at sixth position of beta globin (base pair change: thymine for adenine at sixth codon of β-globin gene). Sickle cell disease refers to any condition in which the production of HbS causes pathophysiological consequences as a result of homozygous inheritance of βS-mutation and referred as either SCD SS or SCA. It includes Sickle cell anemia (SCA), which is the most severe form of the disease but also the compound heterozygotes, where one allele includes sickle cell mutation and second allele includes gene mutation other than the sickle cell mutation, such as HbC, beta thalassemia, HbD, and HbO [1, 2]. Homozygous SS patients are the ones most likely associated with ulcerations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rees DC, Williams TN, Gladwin MT. Sickle cell disease. Lancet. 2010;376:2018–31.
Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore). 2005;84:363–76.
Parent F, Bachir D, Inamo J, et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med. 2011;365:44–53.
Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK. Leg ulcers in sickle cell disease. Am J Hematol. 2010;85:831–3.
Nouraie M, Lee JS, Yingze ZY. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica. 2013;98:464–72.
Bunn HF, Nathan DG, Dover GJ, et al. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood. 2010;116:687e92.
Nguyen VT, Nassar D, Batteux F, et al. Delayed healing of sickle cell ulcers is due to impaired angiogenesis and CXCL12 secretion in skin wounds. J Invest Dermatol. 2016;136:497–506.
Monfort JB, Senet P. Leg ulcers in sickle-cell disease: treatment update. Adv Wound Care. 2020;9(6):348–56.
Serjeant GR. Leg ulceration in sickle cell anemia. Arch Int Med. 1974;133:690–4.
Altman IA, Kleinfelder RE, Quigley JG, Ennis WJ, Minniti CP. A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease. Int Wound J. 2016;13:1315–24.
Stevens DM, Shupack JL, Javid J, Silber R. Ulcers of the leg in thalassemia. Arch Dermatol. 1977;113:1558–60.
Wethers DL, Ramirez GM, Koshy M, Steinberg MH, Phillips G, Siegel RS, et al. Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group. Blood. 1994;84:1775–9.
Minniti CP, Gorbach AM, Xu D, Hon YY, Delaney KM, Seidel M, et al. Topical sodium nitrite for chronic leg ulcers in patients with sickle cell anaemia: a phase 1 dose-finding safety and tolerability trial. Lancet Haematol. 2014;1:e95–103.
La Grenade L, Thomas PW, Serjeant GR. A randomized controlled trial of solcoseryl and duoderm in chronic sickle-cell ulcers. West Indian Med J. 1993;42:121–3.
Garwood CS, Kim PJ, Matai V, et al. The use of bovine collagen-glycosaminoglycan matrix for atypical lower extremity ulcers. Wounds. 2016;28:298–305.
Reindorf CA, Walker-Jones D, Adekile AD, Lawal O, Oluwole SF. Rapid healing of sickle cell leg ulcers treated with collagen dressing. J Natl Med Assoc. 1989;81:866–8.
Alikhan MA, Carter G, Mehta P. Topical GM-CSF hastens healing of leg ulcers in sickle cell disease. Am J Hematol. 2004;76:192.
Serjeant GR, Galloway RE, Gueri MC. Oral zinc sulphate in sickle-cell ulcers. Lancet. 1970;2:891–2.
Frost ML, Treadwell P. Treatment of sickle cell leg ulcers with pentoxifylline. Int J Dermatol. 1990;29:375–6.
Eckman JR. Leg ulcers in sickle cell disease. Hematol Oncol Clin North Am. 1996;10:1333–44.
Serjeant GR, Howard C. Isoxsuprine hydrochloride in the therapy of sickle cell leg ulceration. West Indian Med J. 1977;26:164–6.
Voskaridou E, Christoulas D, Bilalis A, et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood. 2010;115:2354–63.
Lanzkron S, Strouse JJ, Wilson R, et al. Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med. 2008;148:939–55.
Ashby RL, Gabe R, Ali S, et al. Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (venous leg ulcer study IV, VenUS IV): a randomized controlled trial. Lancet. 2014;383:871–9.
Barwell JR, Davies CE, Deacon J, et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trial. Lancet. 2004;363:1854–9.
Weinzweig N, Schuler J, Marschall M, Koshy M. Lower limb salvage by microvascular free-tissue transfer in patients with homozygous sickle cell disease. Plast Reconstr Surg. 1995;96:1154–61.
Mauck KF, Asi N, Undavalli C, et al. Systematic review and meta-analysis of surgical interventions versus conservative therapy for venous ulcers. J Vasc Surg. 2014;60:60S–70S.
Gohel MS, Heatley F, Liu X, et al. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med. 2018;378:2105–14.
Holm JS, Toyserkani NM, Sorensen JA. Adipose-derived stem cells for treatment of chronic ulcers: current status. Stem Cell Res Ther. 2018;9:142.
Burgos-Alonso N, Lobato I, Hernández I, et al. Adjuvant biological therapies in chronic leg ulcers. Int J Mol Sci. 2017;18:E2561.
Meneses JV, Fortuna V, de Souza ES, et al. Autologous stem cell-based therapy for sickle cell leg ulcer: a pilot study. Br J Haematol. 2016;175:949–55.
Connor JL Jr, Minniti CP, Tisdale JF, Hsieh MM. Sickle cell anemia and comorbid leg ulcer treated with curative peripheral blood stem cell transplantation. Int J Low Extrem Wounds. 2017;16:56–9.
White J, Ivins N, Wilkes A, Carolan-Rees G, Harding KG. Non-contact low-frequency ultrasound therapy compared with UK standard of care for venous leg ulcers: a single-centre, assessor-blinded, randomised controlled trial. Int Wound J. 2016;13:833–42.
Dumville JC, Land L, Evans D, Peinemann F. Negative pressure wound therapy for treating leg ulcers. Cochrane Database Syst Rev. 2015;7:CD011354.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Prasad, R., Pandey, M. (2023). Sickle Cell Anemia and Ulcer. In: Khanna, A.K., Tiwary, S.K. (eds) Uncommon Ulcers of the Extremities. Springer, Singapore. https://doi.org/10.1007/978-981-99-1782-2_18
Download citation
DOI: https://doi.org/10.1007/978-981-99-1782-2_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-1781-5
Online ISBN: 978-981-99-1782-2
eBook Packages: MedicineMedicine (R0)